MedPath

Health-related Quality of Life of Patients With Esophageal Cancer After Surgery

Phase 2
Conditions
Esophageal Cancer
Interventions
Procedure: MIE
Procedure: Three-incision thoracotomy
Procedure: Ivor-Lewis esophagectomy
Procedure: Sweet esophagectomy
Registration Number
NCT01349517
Lead Sponsor
Fudan University
Brief Summary

The purpose of this multi-center prospective cohort study is to study the health-related quality of life (HRQL) together with other outcomes of patients with esophageal cancer after surgery in China.

Detailed Description

* To study the influence of health-related quality of life of patients with esophageal cancer before and after surgery.

* To compare the impact of different procedures on the the health-related quality of life of patients with esophageal cancer.

* To compare morbidities and oncological results(3,5- year survival) from different procedures.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Clinical stage I/II esophageal cancer
  • Normal blood test of basic metabolism panel
  • Pulmonary function: FEV1 > 1.2L, FEV1% > 50%, DLCO > 50%
  • Heart function: NY grade I and grade II
Exclusion Criteria
  • Mental disorders
  • Combination with other cancers
  • With a previous history of thoracic or ventral surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MIE GroupMIEThe patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)
Three-incision esophagectomy groupThree-incision thoracotomyThe patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)
Ivor-Lewis esophagectomy groupIvor-Lewis esophagectomyThe patients in this group would underwent Ivor-Lewis esophagectomy
Sweet esophagectomy groupSweet esophagectomyThe patients in this group would underwent Sweet esophagectomy.
Primary Outcome Measures
NameTimeMethod
Health related quality of lifepostoperative 2 year

Health related quality of life from the different precedure groups (assessed by EORTC QLQ C-30 and OES-18)

Secondary Outcome Measures
NameTimeMethod
Morbidity Mortality Survival rate5 years

* Perioperative morbidity and mortality from the different precedure groups.

* 3-and 5-year survival rate between the groups.

Trial Locations

Locations (1)

Zhong Shan Hospital, Fu Dan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath